Gainers Adaptimmune Therapeutics plc (NASDAQ: ADAP) shares jumped 127.8% to close at $11.07 on Friday after the company announced updated data from its ADP-A2M4 Phase 1 trial at the American Society for Clinical Oncology Annual Meeting.
Benzinga · 3天前
50 Stocks Moving In Friday's Mid-Day Session
Benzinga · 5天前
65 Biggest Movers From Yesterday
Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) shares climbed 386.3% to close at $19.21 on Thursday after the company announced the development program for its AB201 treatment of coronavirus associated with coagulopathy.